Ahlam Shary J. Hazazi

Overview on Juvenile Idiopathic Arthritis: A Review

Ahlam Shary J. Hazazi, Badaya Awadh M. Alshehri, Yara Abdulrahman Alali, Rahf Mohammed I. Alqarni, Ibtisam Shary J. Hazazi, Nujud Abdulqader Albalawi, Dimah Mohammed A. Abu Murad, Atheer Mansour E Alatawi, Nouf Ali Alatawi & Maisaa Mokhtar M. Yousuf · Journal of Pharmaceutical Research International · 2021

Juvenile idiopathic arthritis (JIA) is a broad term that refers to a clinically heterogeneous group of arthritis that develops before the age of 16 and has no recognized cause. JIA treatment has evolved during the last two decades. Clinical trials research has been directed at mo...

Open access Research Article 10.9734/jpri/2021/v33i40B32273

Overview on Causes and Updated Management of Favism

Mohammed Hussen Sheikh, Ahlam Shary J. Hazazi, Ashwaq Nafea O. Alanazi, Ibtisam Shary J. Hazazi, Amal Abutaleb M. Qaysi, Yara Abdulrahman Alali, Badaya Awadh M. Alshehri, Ohoud Abdullah Almutari, Rawan Hamdi Bedaiwi, Rawan Hamoud M. Alatawi, Rahf Mohammed Alqarni, Alanoud Abdullah Alharbi, Rawan Ahmed H. Alshehri, Rinad Rasheed M. Alrashidi & Mona Awad O. Al Balawi · Journal of Pharmaceutical Research International · 2021

Favism is most common in those who have G6PD deficiency from the Mediterranean region. As hemolytic anaemia is the most common complication of G6PD deficiency, and it can be life-threatening in certain people. Infection, hyperglycemia, certain meals, and certain drugs can all cau...

Open access Research Article 10.9734/jpri/2021/v33i47B33121